News Search Results
Dec 03, 2025, 12:59 ET U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Dec 03, 2025, 12:50 ET Natural Food Colors Market Set to Grow to USD 4.03 B by 2035, Creating a Global Standard-Bearer for Clean-Label Ingredients
Future Market Insights (FMI) is a leading provider of market intelligence, offering in-depth research across pharmaceuticals, healthcare, biotechnology, and life sciences. With a global research network and advanced analytical frameworks, FMI supports manufacturers, investors, policymakers, and
More news about: Future Market Insights
Dec 03, 2025, 10:30 ET Preclinical Imaging Market worth $4.39 billion by 2030 | MarketsandMarkets™
targeting.By end user, pharmaceutical & biotechnology companies are the largest end-user segment in the preclinical imaging market in 2024.the preclinical imaging market is segmented into pharmaceutical & biotechnology companies, academic & research centers, contract research
More news about: MarketsandMarkets
Dec 03, 2025, 09:23 ET Shulman Rogers Announces Elevation of Two New Shareholders
He represents startup and mature private and public companies and investors across a broad range of industries, including fintech, biotechnology, pharmaceutical, life sciences, consumer goods, retail and financial services.Clients appreciate Hunter's perspective, his diligence and
More news about: Shulman Rogers
Dec 03, 2025, 09:05 ET Monod Bio and Gator Bio Partner to Develop Next-Generation Biosensors for Advanced Life Science Research
Gator's, we're enabling partners to rapidly bring breakthrough products to market."About Monod BioMonod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design, co-founded by Daniel Silva Manzano,
More news about: Monod Bio
Dec 03, 2025, 09:05 ET FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist Market Through 2035
Future Market Insights (FMI) is a leading provider of market intelligence, offering in-depth research across pharmaceuticals, healthcare, biotechnology, and life sciences. With a global research network and advanced analytical frameworks, FMI supports manufacturers, investors, policymakers, and
More news about: Future Market Insights, Inc.
Dec 03, 2025, 09:03 ET Granata Bio Reports Strong Enrollment Momentum in Pivotal Phase III GRACE Study of Investigational Gonadotropin for Assisted Reproductive Technology
BOSTON, Dec. 3, 2025 /PRNewswire/ -- Granata Bio Corporation, a biotechnology company advancing innovative reproductive health solutions, announced strong momentum in its pivotal Phase III clinical study, with multiple subjects
More news about: Granata Bio
Dec 03, 2025, 09:00 ET CABIO Showcases Life-Stage Nutrition Innovation at Fi Europe 2025 Paris as the New Global Headquarter Opens
Dec. 3, 2025 /PRNewswire/ -- At the 30th milestone edition of Food Ingredients Europe 2025, the leading Chinese biotechnology company CABIO showcases its comprehensive nutritional ingredients portfolio while simultaneously announcing the official
More news about: CABIO Biotech (Wuhan) Co, Ltd
Dec 03, 2025, 08:30 ET Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic Success, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Dec 03, 2025, 08:00 ET STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced that it has been awarded a contract
More news about: STRM.BIO
Dec 03, 2025, 08:00 ET Avance Biosciences Launches Potency & Cell-Based Assay Center in Houston
testing, Avance supports clients from discovery through commercial release. Based in Houston, Texas, the company serves a global pharmaceutical and biotechnology client base.Learn more at
More news about: Avance Biosciences, Inc.
Dec 03, 2025, 07:34 ET Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Dec. 3, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, today highlighted key milestones, achievements and clinical progress
More news about: Virax BioLabs Group Limited
Dec 03, 2025, 05:04 ET Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results
clinical trial solution income represents the service income earned from our customers mainly including biopharmaceutical companies and leading biotechnology companies. We match qualified and suitable patients for enrollment in clinical trials for our customers and generate digital clinical trial solution
More news about: Waterdrop Inc.
Dec 03, 2025, 05:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Lawrence He, CEO, Rxilient.About Formosa Pharmaceuticals, Inc.Formosa Pharmaceuticals, Inc. (6838.TW) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation technology (APNT®),
More news about: Formosa Pharmaceuticals Inc.,
Dec 03, 2025, 04:01 ET CABIO Showcases Life-Stage Nutrition Innovation at Fi Europe 2025 Paris as the New Global Headquarter Opens
Dec. 3, 2025 /PRNewswire/ -- At the 30th milestone edition of Food Ingredients Europe 2025, the leading Chinese biotechnology company CABIO showcases its comprehensive nutritional ingredients portfolio while simultaneously announcing the official opening of its new Global
More news about: CABIO Biotech (Wuhan) Co, Ltd
Dec 02, 2025, 19:43 ET Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®
(aflibercept-boav), as well as the novel biologic ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Dec 02, 2025, 18:48 ET Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders
(including as a director of Invea Therapeutics, which is studying transformational precision medicines) and direct experience in delivering high-premium biotechnology transactions that is conspicuously absent from the current Board and is essential to evaluating Neuphoria's remaining pipeline and partnership opportunities.
More news about: Lynx1 Capital Management LP
Dec 02, 2025, 16:40 ET New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
LinkedIn. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities.
More news about: Eisai Inc.
Dec 02, 2025, 14:00 ET Blood Cancer United, formerly The Leukemia & Lymphoma Society, Announces New Funding for Lifesaving Cancer Breakthroughs
diagnostic strategies and therapeutic options for follicular lymphoma.Auron Therapeutics, a Massachusetts-based clinical-stage biotechnology company, uses AI and machine learning to streamline and accelerate drug development. This speeds up finding new drug targets, the safest and most
More news about: Blood Cancer United® formerly The Leukemia & Lymphoma Society
Dec 02, 2025, 13:44 ET Biodegradable Industrial Polymers for Circular Economy Applications Market worth USD 48.56 BN by 2032 | Credence Research
assessment indicates a highly dynamic and innovation-driven marketplace featuring global biopolymer producers, industrial consortiums, emerging biotechnology firms, and circular economy solution providers. Leading companies are increasingly investing in R&D partnerships, green chemistry innovation,
More news about: Credence Research Inc.
Dec 02, 2025, 10:30 ET AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the European Union (EU)
CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- AOB Pharma, Inc. ("AOBiome"), a leading clinical-stage biotechnology company focusing on inflammatory skin conditions with their lead asset B244 for the treatment of mild to moderate atopic dermatitis (AD) and pruritus,
More news about: AOBiome Therapeutics
Dec 02, 2025, 10:07 ET Katalyze AI Appoints Chief AI Officer to Advance Agentic AI Capabilities in Pharmaceutical Manufacturing
from it, and enable real-time decision making in pharmaceutical manufacturing.As a co-founder of Deep Genomics, one of the AI pioneers in biotechnology, he led the development of the core scientific computing platform, GenomeKit, for genomic analysis and developed deep learning models for splicing
More news about: Katalyze AI
Dec 02, 2025, 09:53 ET Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
www.OSR-Holdings.com.About Vaximm AGVaximm AG is a privately held Swiss-German biotechnology company and a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH). Vaximm's proprietary orally administered T-cell vaccination platform harnesses live,
More news about: OSR Holdings
Dec 02, 2025, 09:05 ET Flywheel Launches Validated Imaging Solution to Accelerate Decision-Making Across the Clinical Trial Ecosystem
automating research workflows and preparing data for AI development. Flywheel's comprehensive solution is designed to allow pharmaceutical and biotechnology companies, academic medical centers, AI developers and medical device manufacturers to realize optimum value out of their imaging data assets. For
More news about: Flywheel
Dec 02, 2025, 09:00 ET Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health
-- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in
More news about: Yuyu Pharma